Clinical effects of lamivudine combined with adefovir dipivoxil and entecavir alone in 48-week treatment of HBeAg-positive chronic hepatitis B: preliminary comparative study
ObjectiveTo compare treatment outcome, drug resistance rate, and safety between initial combination therapy with lamivudine (LAM) plus adefovir dipivoxil (ADV) and monotherapy with entecavir (ETV) in the treatment of HBeAg-positive chronic hepatitis B (CHB). MethodsFifty-six HBeAg-positive CHB patie...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2013-07-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Subjects: | |
| Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=5393&ClassID=67102053 |